AID System

DEVICE5 trials

Sponsors

Eli Lilly and Company

Conditions

Type 1 Diabetes MellitusType1 Diabetes Mellitus

Phase 1

A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

CompletedNCT03367390

Eli Lilly and CompanyType1 Diabetes Mellitus

Start: 2017-11-08End: 2018-02-09Updated: 2018-03-15

Unknown Phase

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)

CompletedNCT03743285

Eli Lilly and CompanyType 1 Diabetes Mellitus

Start: 2018-11-14End: 2019-01-28Updated: 2019-02-19

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges

CompletedNCT03848767

Eli Lilly and CompanyType 1 Diabetes Mellitus

Start: 2019-02-20End: 2019-04-01Updated: 2019-04-23

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus

CompletedNCT03849612

Eli Lilly and CompanyType 1 Diabetes Mellitus

Start: 2019-02-21End: 2019-03-27Updated: 2019-04-25

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes

CompletedNCT03890003

Eli Lilly and CompanyType 1 Diabetes Mellitus

Start: 2019-03-28End: 2019-05-06Updated: 2019-06-05

Related Papers

Predictive Low-Glucose Suspend Necessitates Less Carbohydrate Supplementation to Rescue Hypoglycemia: Need to Revisit Current Hypoglycemia Treatment Guidelines

Diabetes Technology & Therapeutics2021-02-0318 citations

Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies

Diabetes Technology & Therapeutics2020-09-179 citations